Manufacturer
84 recalls in our database name Teva Pharmaceuticals USA, Inc. as the manufacturing or recalling firm.
Of the 84 recalls from Teva Pharmaceuticals USA, Inc. we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 9 (11%) are Severe.
The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.
Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.
Teva Pharmaceuticals is recalling specific lots of Jolessa tablets because they failed appearance specifications. The recall is nationwide.
Teva Pharmaceuticals is recalling specific lots of Clonazepam orally disintegrating tablets because they failed content uniformity specifications.
Teva Pharmaceuticals USA is recalling specific lots of Terazosin Hydrochloride Capsules because a foreign capsule was found in one bottle.
Teva Pharmaceuticals is recalling 13,232 bottles of Cabergoline 0.5 mg tablets because the product may not meet impurity specifications over its shelf life.
Teva Pharmaceuticals is recalling specific lots of Copaxone (glatiramer acetate) injection due to the presence of a foreign particle identified from a customer complaint.
Teva Pharmaceuticals is recalling 2,268 bottles of Metoprolol Tartrate 50 mg tablets in Ohio because some tablets may not meet weight specifications.
Teva Pharmaceuticals is recalling specific lots of Zeosa chewable oral contraceptive tablets because they may not meet impurity specifications.
Teva Pharmaceuticals is recalling Mefloquine Hydrochloride 250 mg tablets because they may be underweight or overweight.
Teva Pharmaceuticals is recalling 40,750 dispensers of Jolessa contraceptive tablets because some packages may be missing placebo tablets.
Community-sourced company facts from Wikidata, not from any recall agency. This is background on the corporate entity — it says nothing about the recall(s) listed on this page, which come from the agency source notice above.
Teva Pharmaceuticals CR
company in Prague, Czechia
Source: Wikidata (Q41567143), licensed CC0. Wikidata is community-edited and may not reflect the current corporate structure.